Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259909 · ClinicalTrials.gov registry record
Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 259
- Enrollment target
NCT00259909 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 259 participants.
The verdict
NCT00259909 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 259 participants
- Enrollment target
Study Summary
The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic obstructive pulmonary disease (COPD). This questionnaire will aim to detect an acute exacerbation and resolution of exacerbation from the patient's perspective. At a later stage of development, this questionnaire will be able to measure the effect of anti bacterials in the treatment of acute exacerbations of COPD (AECOPD). This study will evaluate the factor structure, validity, reliability, and responsiveness of the GSK questionnaire in subjects who experience acute exacerbations of their COPD.
Interventions
- OTHER St. George's Respiratory Questionnaire
- OTHER GSK questionnaire
- OTHER Acute Short Form 12 version 2
- OTHER Global Efficacy questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2005-11-02 |
| Est. Completion | 2006-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00259909
The ClinicalTrials.gov registry entry for NCT00259909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which St. George's Respiratory Questionnaire is the first listed.
NCT00259909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00259909 about?
NCT00259909 is a clinical study titled "Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)". The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic obstructive pulmonary disease (COPD). This questionnaire will aim to detect an acute exacerbation and resolution of exacerbation...
What is the current status of trial NCT00259909?
This trial is currently completed. The enrollment target is 259 participants. The study started on 2005-11-02. Estimated completion is 2006-11-07.
What interventions are being tested in trial NCT00259909?
The interventions under investigation include: St. George's Respiratory Questionnaire (OTHER), GSK questionnaire (OTHER), Acute Short Form 12 version 2 (OTHER), Global Efficacy questionnaire (OTHER).
Who is sponsoring clinical trial NCT00259909?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.